Furthermore, in osteosarcoma patient-derived primary tissues, the inhibition of the Notch pathway downregulates stemness-related gene expression, such as CD133, likely by remodeling the surrounding tumor microenvironment [63]. The gene discussed is PROM1; the disease is neoplasm.